Erica Conroy, Ph.D., Vice President of Specialty, CoverMyMeds Meagan Sampogna, Ph.D., RHIA, Vice President, Business Transformation, RxCrossroads by McKesson
Advertisement
Articles by Erica Conroy, Ph.D., Vice President of Specialty, CoverMyMeds Meagan Sampogna, Ph.D., RHIA, Vice President, Business Transformation, RxCrossroads by McKesson
Advertisement
Latest Updated Articles
- A Change of Pace for Accessing Specialty Medications – Access for More Patients
Published: October 1st 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Commerce
1
Mark Cuban Cost Plus Drug Company Adds Starjemza to Prescription Drug Portfolio
2
The New Pharma Equation: How DTP, DTC, and DTE are Re-Wiring Healthcare Around Patients
3
Direct-to-Patient (DTP): Who Benefits - and Why It’s Different
4
Why AI-Augmented Traceability Hubs are the Future of Pharma Serialization
5
